This change also reflects potential considerations regarding tolerability, clinical outcomes, and affordability
Maybe they just stopped doing what hurt them, because it hurt, and they got better
This provides marginal benefit compared to semaglutide's seven-day half-life
Boccia L, Gamakharia S, Coester B, Whiting L, Lutz TA, Le Foll C
Chronic low-grade inflammation is increasingly recognised as a key contributor to numerous conditions, including cardiovascular disease, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and certain autoimmune disorders
doi:10.1006/enrs.1999.4003